Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
10 Patents
#68 in Jiangsu
#2,807 in China
#56,047 in the World
Ascentage Pharma (Suzhou) Co., Ltd.
Forward Citations = 0
30 inventors:
Ascentage Pharma (Suzhou) Co., Ltd.
Forward Citations = 0
Loading Chart...
Loading Chart...
30 inventors (with patents filed for the assignee):
Dajun Yang (4 out of 22 patents)
Yifan Zhai (4 out of 22 patents)
Yanqiong Lin (4 out of 7 patents)
4. Jianfeng Wen (3 out of 9 patents)
5. Tianzhu Wu (2 out of 6 patents)
6. Saijie Zhu (2 out of 3 patents)
7. Jianpeng Feng (2 out of 6 patents)
8. Weidong Li (2 out of 4 patents)
9. Zhenzhong Shao (2 out of 3 patents)
10. Jianyong Chen (2 out of 2 patents)
11. Huirong Lu (1 out of 4 patents)
12. Feng Xu (1 out of 8 patents)
13. Douglas Dong Fang (1 out of 14 patents)
14. Weidong Li (1 out of 3 patents)
15. Qian Jiang (1 out of 2 patents)
10 patents:
Company Overview
Ascentage Pharma (Suzhou) Co., Ltd. is a biopharmaceutical company focused on developing innovative therapies for cancer and age-related diseases. The organization specializes in the discovery and development of small molecule drugs that target apoptosis pathways, aiming to address unmet medical needs in oncology. With a strong emphasis on research and development, Ascentage Pharma operates primarily in Jiangsu, China, contributing to the advancement of precision medicine and enhancing treatment options for patients globally.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ascentage Pharma (Suzhou) Co., Ltd.. Retrieved from https://idiyas.com/company/ascentage-pharma-suzhou
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]